Aethlon Medical, Inc.
AEMD
$1.59
$0.042.58%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 71.83% | -256.45% | 37.48% | -9.16% | -6.02% |
Total Depreciation and Amortization | -1.55% | 0.12% | -2.33% | -0.35% | 0.35% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -96.96% | 2,860.05% | -36.68% | 83.78% | -11.36% |
Change in Net Operating Assets | 30.19% | 48.37% | -297.98% | -57.85% | 257.15% |
Cash from Operations | -2.53% | 16.82% | 9.20% | -26.73% | 31.88% |
Capital Expenditure | -- | 200.00% | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | 200.00% | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -100.00% | 10,711.85% |
Repurchase of Common Stock | -86.21% | 59.15% | -86.84% | 25.49% | 29.17% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -100.23% | 33,326.76% | -86.84% | -100.07% | 12,527.23% |
Foreign Exchange rate Adjustments | -545.83% | 82.35% | -366.67% | 492.31% | 43.48% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -352.96% | 133.74% | 8.11% | -160.97% | 243.49% |